Culture

Personalizing cancer care with improved tumor models

image: Schematic illustrating multiple platforms available for patient-derived models of cancer.

Image: 
Bryan Welm

WASHINGTON, January 21, 2021 -- Cancer is a major, worldwide challenge, and its impact is projected to escalate due to aging and growth of the population. Researchers recognize that new approaches to diagnose and treat deadly cancers, including identifying new drugs to treat cancer, will be essential to curbing the growing impact of the disease.

While decades of investment in research have resulted in substantial improvements in surviving cancer, a key challenge remains in identifying new drugs that improve outcomes for cancer patients, particularly for cancers when tumors have spread throughout the body.

In APL Bioengineering, by AIP Publishing, researchers suggest a major hurdle to identifying new drugs is the paucity of models -- organisms mimicking human cancers in a lab setting -- for cancer research that accurately represent patient tumors. They provide a perspective on strategies for developing models to inform cancer treatment using models from individual patients and where the field needs to go in terms of research in animal systems and in culture systems.

"In addition to having better models for cancer research, we are trying to evolve patient-derived models to the point where we can have speedy and reliable drug testing on patient specimens to help personalize cancer care," said author Alana Welm. "This is the concept of functional precision oncology."

In functional precision oncology, tumor samples from individual patients are tested for susceptibility to various drugs in the context of a patient-derived xenograft or culture system in order to guide patient therapy during the course of their disease.

The researchers suggest an even more powerful approach to accelerating the pace of cancer research would be to couple patient-derived model development with the plethora of clinical trials being run every day.

If clinical data and models were collated and shared along with drug response information, machine learning could facilitate analysis of this big data to discover complex patterns of drug response or resistance across individuals, which could then be further tested in the patient-derived models.

The researchers envision that patients' tumors may be bioinformatically profiled to identify a complex set of features that can be used to predict response to various therapies and informed by functional drug response data collected from previous studies. The researchers believe this would facilitate selection of more effective drugs earlier in treatment, while preventing administration of toxic drugs that offer no benefit.

These types of data could even be integrated with germline DNA sequence variants that predict aberrant drug metabolism and toxicity for an even more personalized approach to reduce mortality from cancer while simultaneously reducing toxicity as much as possible.

Credit: 
American Institute of Physics

Study finds bilateral agreements help developing economies spur foreign investment

EUGENE, Ore. -- Jan. 21, 2021 -- Developing economies suffer from a paradox: they don't receive investment flows from developed economies because they lack stability and high-quality financial and lawmaking institutions, but they can't develop those institutions without foreign funds.

A study co-authored by Brandon Julio, a professor in the Department of Finance at the University of Oregon's Lundquist College of Business, found that bilateral investment treaties, commonly known as BITs, can help developing economies overcome this paradox, but only as long as those countries can demonstrate a commitment to property and contract rights.

Julio published the research, "A BIT Goes a Long Way: Bilateral Investment Treaties and Cross-border Mergers," in a paper that published online Dec. 11 ahead of print in the Journal of Financial Economics with co-authors Vineet Bhagwat of the George Washington University School of Business and Jonathan Brogaard of the Eccles School of Business at the University of Utah.

"Controlling for year-fixed effects, country-pair fixed effects, and other determinants of cross-border merger and acquisition activity, we find that the probability of a cross-border merger taking place in a country's economy more than doubles, increasing from 1.6 percent before the treaty to 4.5 percent after the treaty is signed," the researchers stated.

The researchers argue that even in an era of globalization with global capital flows continuing to gain velocity, developing economies should not overlook the value of bilateral investment treaties to overcome what is known as the Lucas paradox.

The paradox was named for Nobel Laureate Robert Lucas, a University of Chicago economist who articulated it in his seminal 1990 paper in the journal American Economic Review. It demonstrated that funds do not flow to poorer countries despite the fact that returns to capital are higher in the developing world.

By looking at mergers and acquisitions, Julio and his co-authors set out to assess whether bilateral investment treaties help spur investment in developing economies.

Using data from Securities Data Co.'s database on mergers and acquisitions, the researchers analyzed merger data for all countries between 1980 and 2014. They then correlated that data with 1,057 BITs from 139 countries.

The analysis found that both the number and size, in terms of dollars, of cross-border deals increased after a treaty was signed. BITs also made mergers more likely between asset-rich companies or those in asset-intensive industries, like mining or airlines because they decrease the risk of government expropriation of property.

"The basic idea is to provide clear and enforceable rules to protect foreign investment and reduce country or political risks, which should encourage investment," the researchers noted.

But BITs are no panacea, according to Julio, Bhagwat and Brogaard.

If a country has a bad reputation for upholding property rights, or seems politically unstable, corporations will not attempt to do business there even if a BIT is in place. Similarly, if a country is already deemed low risk, then a BIT makes a deal no more likely. Countries with median-level political risk benefit the most from these agreements, the researchers said.

"While the results do not completely resolve the Lucas paradox, and most cross-border capital remains within the borders of developed countries, the proportion of cross-border deals flowing from the developed to the developing world has increased significantly as more and more countries sign BITs," they concluded.

As bilateral investment treaties are difficult and time consuming to negotiate and are often struck between nations with more mature economies, the findings from the research encourages leaders of developing nations to look to BITs as a faster way to attract foreign investments from companies in Europe, America and Japan.

So long as a country can demonstrate a commitment to property and contract rights, these agreements can be effective and can support both local economies and equities markets, the researchers concluded.

Credit: 
University of Oregon

How to get more electric cars on the road

A new study from researchers at MIT uncovers the kinds of infrastructure improvements that would make the biggest difference in increasing the number of electric cars on the road, a key step toward reducing greenhouse gas emissions from transportation.

The researchers found that installing charging stations on residential streets, rather than just in central locations such as shopping malls, could have an outsized benefit. They also found that adding on high-speed charging stations along highways and making supplementary vehicles more easily available to people who need to travel beyond the single-charge range of their electric vehicles could greatly increase the vehicle electrification potential.

The findings are reported today in the journal Nature Energy, in a paper by MIT associate professor of energy studies Jessika Trancik, graduate student Wei Wei, postdoc Sankaran Ramakrishnan, and former doctoral student Zachary Needell SM '15, PhD '18.

The researchers developed a new methodology to identify charging solutions that would conveniently fit into people's daily activities. They used data collected from GPS tracking devices in cars, as well as survey results about people's daily driving habits and needs, including detailed data from the Seattle area and more general data from the U.S. as a whole. Greatly increasing the penetration of electric cars into the personal vehicle fleet is a central feature of climate mitigation policies at local, state, and federal levels, Trancik says. A goal of this study was "to better understand how to make these plans for rapid vehicle electrification a reality," she adds.

In deciding how to prioritize different kinds of improvements in vehicle charging infrastructure, she says, "the approach that we took methodologically was to emphasize building a better understanding of people's detailed energy consuming behavior, throughout the day and year."

To do that, "we examine how different people are moving from location to location throughout the day, and where they are stopping," she says. "And from there we're able to look at when and where they would be able to charge without interrupting their daily travel activities."

The team looked at both regular daily activities and the variations that occur over the course of a year. "The longitudinal view is important for capturing the different kinds of trips that a driver makes over time, so that we can determine the kinds of charging infrastructure needed to support vehicle electrification," Wei says.

While the vast majority of people's daily driving needs can be met by the range provided by existing lower-cost electric cars, as Trancik and her colleagues have reported, there are typically a few times when people need to drive much farther. Or, they may need to make more short trips than usual in a day, with little time to stop and recharge. These "high-energy days," as the researchers call them, when drivers are consuming more than the usual amount of energy for their transportation needs, may only happen a handful of times per year, but they can be the deciding factor in people's decision making about whether to go electric.

Even though battery technology is steadily improving and extending the maximum range of electric cars, that alone will not be enough to meet all drivers' needs and achieve rapid emissions reductions. So, addressing the range issue through infrastructure is essential, Trancik says. The highest-capacity batteries tend to be the most expensive, and are not affordable to many, she points out, so getting infrastructure right is also important from an equity perspective.

Being strategic in placing infrastructure where it can be most convenient and effective -- and making drivers aware of it so they can easily envision where and when they will charge -- could make a huge difference, Trancik says.

"There are various ways to incentivize the expansion of such charging infrastructures," she says. "There's a role for policymakers at the federal level, for example, for incentives to encourage private sector competition in this space, and demonstration sites for testing out, through public-private partnerships, the rapid expansion of the charging infrastructure." State and local governments can also play an important part in driving innovation by businesses, she says, and a number of them have already signaled their support for vehicle electrification.

Providing easy access to alternative transportation for those high-energy days could also play a role, the study found. Vehicle companies may even find it advantageous to provide or partner with convenient rental services to help drive their electric car sales.

In their analysis of driving habits in Seattle, for example, the team found that the impact of either adding highway fast-charging stations or increasing availability of supplementary long-range vehicles for up to four days a year meant that the number of homes that could meet their driving needs with a lower cost electric vehicle increased from 10 percent to 40 percent. This number rose to above 90 percent of households when fast-charging stations, workplace charging, overnight public charging, and up to 10 days of access to supplementary vehicles were all available. Importantly, charging options at residential locations (on or off-street) is key across all of these scenarios.

The study's findings highlight the importance of making overnight charging capabilities available to more people. While those who have their own garages or off-street parking can often already easily charge their cars at home, many people do not have that option and use public parking. "It's really important to provide access -- reliable, predictable access -- to charging for people, wherever they park for longer periods of time near home, often overnight," Trancik says.

That includes locations such as hotels as well as residential neighborhoods, she says. "I think it's so critical to emphasize these high-impact approaches, such as figuring out ways to do that on public streets, rather than haphazardly putting a charger at the grocery store or at the mall or any other public location." Not that those aren't also useful, she says, but public planning should be aiming to expand accessibility to a greater part of the population. Being strategic about infrastructure expansion will continue to be important even as fast chargers fall in cost and new designs begin to allow for more rapid charging, she adds.

The study should help to provide some guidance to policymakers at all levels who are looking for ways to facilitate the reduction of greenhouse gas emissions, since the transportation sector accounts for about a third of those emissions overall. "If you have limited funds, which you typically always do, then it's just really important to prioritize," Trancik says, noting that this study could indicate the areas that could provide the greatest return for those investments. The high-impact charging solutions they identify can be mixed and matched across different cities, towns, and regions, the researchers note in their paper.

The researchers' approach to analyzing high-resolution, real-world driving patterns is "valuable, enabling several opportunities for further research," says Lynette Cheah, an associate professor of engineering systems and design at Singapore University of Technology and Design, who was not associated with this work. "Real-world driving data can not only guide infrastructure and policy planning, but also optimal EV charging management and vehicle purchasing and usage decisions. ... This can provide greater confidence to drivers about the feasibility and operational implications of switching to EVs."

Credit: 
Massachusetts Institute of Technology

Abnormal hyperactivation in the brain may be an early sign of Alzheimer's

Abnormally hyperactive areas in the brain may help better predict the onset of Alzheimer's disease, according to findings of a research team led by Université de Montreal psychology professor Sylvie Belleville, scientific Director of the Institut universitaire de gériatrie de Montréal research centre.

Hyperactivation could be an early biomarker of Alzheimer's disease, the researchers say in their study published today in Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring, co-authored by Belleville and Nick Corriveau-Lecavalier, a doctoral student she supervises.

Worried about their memory

In their research, the team found hyperactivation in certain brain areas in people not yet diagnosed with Alzheimer's but who were worried about their memory and who exhibited risk factors for the disease.

The study marks an important milestone in this research area, as the hyperactivation of regions susceptible to the Alzheimer's as shown by functional magnetic resonance imaging (fMRI) was observed in people with no clinical symptoms and before the onset of cognitive impairments detected with standardized tests.

"This study indicates that abnormal activation in these areas may be observed many years before diagnosis," said Belleville.

This finding is crucial to the advancement of knowledge about the disease., she continued.

"Alzheimer's disease is progressive and may emerge in the brain 20 to 30 years before diagnosis. It is therefore very important to pinpoint biomarkers - that is, physical and detectable signs of the disease - and to better understand the initial effects on the brain. Hyperactivation could therefore represent one of the first signs of Alzheimer's disease."

An inverse U-shape

The team observed that, as the disease progresses, neuronal activation follows an inverse U-shape trajectory. Indeed, activation in certain areas of the brain in the early stages of Alzheimer's may significantly increase before the neuronal loss that is caused by the disease leads to a clear decrease in activation.

"This form may characterize the underlying pathological process and help doctors determine the stage of the disease," explained Corriveau-Lecavalier, the study's first author. "When combined with other indicators such as blood work and cognitive tests, this type of neuroimaging investigation could help with possible earlier detection."

For their study, the team used data from the Consortium for the Early Identification of Alzheimer's Disease to study brain activation in groups of individuals at a high risk of developing Alzheimer's disease who had performed a memory task while being scanned with fMRI. One group consisted of 28 individuals who were concerned about their memory but who did not show cognitive impairments on traditional clinical tests. The other group included 26 individuals with mild cognitive impairments.

The researchers found that the individuals in the first group, or those with memory complaints but who did not show objective cognitive impairments, had abnormally high levels of activation in multiple key regions of the brain affected by Alzheimer's disease. Individuals with mild cognitive impairments, who are considered to be at a more advanced stage of the disease, tended to show decreased activation in these brain regions.

Credit: 
University of Montreal

Mitochondrial mutation increases the risk of diabetes in Japanese men

image: Su-Jeong Kim, research assistant professor of gerontology

Image: 
Stephanie Kleinman

A new study of Type 2 diabetes (T2D) in Japanese populations has uncovered a previously uncharacterized genetic variant that puts male carriers at greater risk for the disease, as well as the mechanism by which it does so. The impact of the variant was most pronounced in sedentary men; those with the variant had a 65% greater rate of T2D than sedentary men without it.

Researchers from the University of Southern California, along with colleagues in Japan, led by Professor Noriyuki Fuku of Juntendo University, found higher rates of harmful belly fat and T2D among Japanese men with a specific mitochondrial gene variant. This variant, in the site of the mitochondrial peptide MOTS-c, is found only in East Asian populations and was shown, in human and mice data, to prevent the normal production of MOTS-c, and to diminish the beneficial action the exercise-mimicking peptide usually performs in preventing weight gain and normalizing metabolism. Furthermore, carriers of the deleterious variant were secreting high levels of a bio-inactive form of the peptide in an attempt to compensate for its deficiency.

The findings, published Jan 19 in the journal Aging, also suggest that moderate to vigorous levels of daily physical activity can offset the increased risk posed by the variant allele. Researchers say this underscores the power of gene-environment interactions and highlights the role exercise can play in preventing the disease.

"Our study suggests that individuals with this particular variant can modify their genetic risk by adopting an exercise regime," said co-lead author Su-Jeong Kim, a research assistant professor at the USC Leonard Davis School. "A deeper understanding of the effects of this genetic variation will provide a basis for developing physical activity strategies to maximize the benefits of exercise in T2D."

The study also provides a possible explanation as to why T2D is more common in East Asian populations. It is estimated that 7-10% of East Asians carry this variant and the research team believes their results are generalizable to other East Asians, including Koreans and Northern Chinese. According to the International Diabetes Federation, close to 40% of the world's T2D cases come from the region that includes China, Korea and Japan.

"This is particularly noteworthy because, although East Asian populations have lower mean body mass index (BMI) than Caucasian populations, they have a higher susceptibility to T2D," said co-senior author Pinchas Cohen, professor of gerontology, medicine and biological sciences and dean of the USC Leonard Davis School. "These results provide us with both a better understanding of how mitochondrial genetic variants can contribute to diseases and insights for developing precision-medicine-based therapies for treating them including replacing the defective peptide with drugs that mimic its actions."

These findings were male-specific. The variant did not affect females in either the human or mouse data. Researchers speculate this is due to an interaction between mitochondrial peptides and hormones but say the mechanism is currently unclear.

More on MOTS-C

MOTS-c is one of several more recently identified hormones that are encoded in the DNA of mitochondria, the "powerhouses" of cells that convert food into energy; most other hormones are encoded in DNA in the nucleus. Cohen and Changhan David Lee, an assistant professor at the USC Leonard Davis School, first described MOTS-c in 2015, along with its role in
restoring insulin sensitivity and counteracting diet-induced and age-dependent insulin resistance - effects commonly associated with exercising. In a separate paper published January 20, in Nature Communication, the same authors demonstrated that MOTS-c has "exercise mimetic" activities.

The current paper in Aging found that a variant at the coding region of MOTS-c was responsible for changing the amino acid of the MOTS-c peptide. Individuals carrying the C allele, rather than the more prevalent A allele, produced a form of MOTS-c called K14Q MOTS-c that lacked health-promoting features of the more common form.

The study found that the C allele MOTS-c variant was less effective as a metabolic regulator in cell and animal models and is associated with suppressed insulin sensitizing effects and higher body fat. In male mice, MOTS-c administration significantly reduced weight gain from a high-fat diet. In contrast, K14Q MOTS-c failed to protect against high-fat-diet-induced weight gain. In addition, mice administrated with MOTS-c performed better on glucose tolerance tests than K14Q injected mice.

"We showed that K14Q MOTS-c has a reduced effect on insulin sensitivity and weight gain compared to the more common form of MOTS-c in mice and speculate that this variant increases the prevalence of T2D in sedentary men because the C allele carriers produce the less effective form of MOTS-c," said Kim.

Comparing Cohorts

The researchers next studied the effect of the C allele variant on T2D in three cohorts of individuals of Japanese descent: the Japan Multi-Institutional Collaborative Cohort Study (J-MICC), which includes 4,963 men and 6,889 women; Japanese-American subjects in the Multiethnic Cohort (MEC) study, which includes 1,810 men and 1,577 women of Japanese descent living in the US; and the Tohoku Medical Megabank project (TMM), which includes 4,471 males and 7,817 females.

Meta-analysis of the three cohorts showed that males with the C-allele had higher rates of T2D. Regardless of exercise status, the C-allele increased the risk of T2D by more than one third.

The J-MICC study contained measures of daily activities. The researchers performed a comparison and found that among the least active men, those with the C allele had a 65% greater rate of T2D than men with the A allele. This higher rate of disease was not seen in C-allele men who engaged in more than 40 minutes of daily moderate to vigorous physical activity.

These results strongly suggest that a combination of sedentary lifestyle and the C allele variant contributes to elevated T2D risk, according to the researchers, who posit that the variant may have evolved to best fit living conditions characterized by highly active lifestyles and limited caloric intake. In the past this might have presented an advantage, but in the twenty-first century, it is a metabolic liability, they say.

"As MOTS-c analogues are currently in clinical development for the treatment of T2D complications, the recognition that activity levels can affect T2D risk in carriers of this SNP may inform future clinical trials," said Cohen. "This novel discovery suggests that additional ethnic-specific mitochondrial variants may be involved in metabolic disease risk. It also provides a blueprint for additional investigations into the mechanisms behind how mitochondria regulate disease and the search for potential mitochondria-based therapeutics."

Credit: 
University of Southern California

Study finds racial disparities in breast cancer prognosis testing

Black women have higher recurrence and mortality rates than non-Hispanic white women for certain types of breast cancer, according to a University of Illinois Chicago researcher's study published recently in JAMA Oncology.

Dr. Kent Hoskins, associate professor in the UIC College of Medicine's division of hematology/oncology, and co-leader of the Breast Cancer Research group in the University of Illinois Cancer Center, published the study, "Association of race/ethnicity and the 21-gene Recurrence Score with breast cancer-specific mortality among US women" in the Jan. 21 online issue.

Hoskins and the research team sought to discover if breast cancer-specific mortality among women with estrogen receptor-positive, axillary node-negative breast cancer differs by race within risk categories defined by the Oncotype Recurrence Score, or RS, which is a genomic test that analyzes the activity of a group of genes that can affect how a cancer is likely to behave and respond to treatment. They also wanted to find out if the prognostic accuracy of the RS differs by race.

"Using data from the national SEER registry that included more than 70,000 patients across the U.S., we found there was a much higher mortality rate for African American women with the most common subtype of breast cancer event when they are diagnosed at an early stage," Hoskins said.

Women with hormone-dependent breast cancer typically have a favorable prognosis, but Hoskins found that even after adjusting for age at diagnosis, tumor stage and treatment, there is still a significant mortality gap between Black and non-Hispanic white women with axillary node-negative, hormone-dependent tumors that have a comparable RS.

The research also found that Black women are more likely to have a high-risk RS, indicating that Black women disproportionately develop biologically aggressive tumors. According to Hoskins, the underlying cause of this is unknown, but this is an active area of research among UI Cancer Center investigators. The Oncotype test also had lower prognostic accuracy in Black women, indicating that genomic tumor tests used to identify candidates for chemotherapy may require re-calibration in populations with greater racial and ethnic diversity, according to Hoskins' research.

The paper's findings are based on a retrospective, population-based cohort study database that contained data on women 18 years and older who were diagnosed with first primary stages I-III, estrogen receptor-positive breast cancer between 2004-2015.

"This study highlights a widespread problem that may contribute to health disparities," Hoskins said. "Research to develop and validate new medical tests frequently have inadequate representation of individuals from racial/ethnic minority groups. Because of this, new tests may be less accurate in individuals who belong to minority groups."

Because the RS is used by oncologists to make informed treatment decisions on the need for chemotherapy, Hoskins' study points out that the Oncotype RS model needs to be recalibrated to reflect racial differences.

The same lack of adequate representation of individuals from racial/ethnic minority groups plagues clinical trials of new cancer treatments, according to Hoskins.

"Our study is just one more example of how exclusion of minority patients from research can lead to inequities in health outcomes," he said.

While the study concluded that there is a disparity in mortality among Black women with early-stage breast cancer, further research is needed to understand the role of tumor biology and of structural violence in this disparity. Structural violence refers to systematic ways in which social structures harm or otherwise disadvantage individuals. Hoskins said the next step is to look at population health data and molecular data to determine the mechanisms driving the differences.

"We really think there is an intersection between social determinants of health and tumor biology and that is what we are trying to understand with follow-up studies," Hoskins said.

In addition to Hoskins, the research team included Dr. Oana Danciu and Dr. Gregory Calip, who are both UI Cancer Center members, and Dr. Naomi Ko of Boston University.

Credit: 
University of Illinois Chicago

Giant sand worm discovery proves truth is stranger than fiction

image: Field excursion at Yehliu.

Image: 
Masakazu Nara

Simon Fraser University researchers have found evidence that large ambush-predatory worms--some as long as two metres--roamed the ocean floor near Taiwan over 20 million years ago. The finding, published today in the journal Scientific Reports, is the result of reconstructing an unusual trace fossil that they identified as a burrow of these ancient worms.

According to the study's lead author, SFU Earth Sciences PhD student, Yu-Yen Pan, the trace fossil was found in a rocky area near coastal Taiwan. Trace fossils are part of a research field known as ichnology. "I was fascinated by this monster burrow at first glance," she says. "Compared to other trace fossils which are usually only a few tens of centimetres long, this one was huge; two-metres long and two-to-three centimetres in diameter. The distinctive, feather-like structures around the upper burrow were also unique and no previously studied trace fossil has shown similar features."

Pan and SFU Earth Sciences professor Shahin Dashtgard are part of an international team that named the homes of these ancient giant worms Pennichnus formosae. Pan initiated the work while completing her M.Sc. degree under the supervision of Professor Ludvig Löwemark, from the Department of Geosciences at National Taiwan University, Taiwan.

After investigating 319 specimens preserved in early Miocene strata (22 million - 20 million years ago) in northeast Taiwan, the morphological model of this trace fossil was constructed.

"Shahin encouraged us to reach out to marine biologists, marine photographers and aquarium keepers to compare the burrows to biological analogs, which enabled us to reach the conclusion that this trace fossil was produced by giant, ambush-predatory worms," says Pan.

The modern-day Bobbit worm, which is also large and predatory, is sometimes called the 'sand striker,' sensing prey with its antennae, then grabbing them with its powerful jaws, and retreating into its burrow. When it burrows, its body occupies the whole burrow which explains the two-metre-long burrow observed in Pennichnus.

Further analysis revealed a high concentration of iron around the upper burrow, leading researchers to believe the worm secreted mucus to reinforce and rebuild its burrow wall after each feeding.

Modern Bobbit worm burrow openings are similar to that of Pennichnus, suggesting that the sediment collapsed into the burrow upon retreating or pulling still live prey below the seafloor.

Marine predatory worms have existed since the early Palaeozoic (> 400 million years ago), but their soft tissue bodies decay leaving little trace of their existence behind. Pennichnus formosae is believed to be the first known trace fossil produced by a sub-surface ambush predator, allowing researchers a rare opportunity to learn more about this ancient sand striker's behaviour.

Credit: 
Simon Fraser University

Study reveals new insights into the link between sunlight exposure and kidney damage

A new collaborative study from researchers at the Geisel School of Medicine at Dartmouth and the University of Washington (UW) and published in the Proceedings of the National Academy of Sciences (PNAS), reveals unexpected insights into how skin exposure to ultraviolet (UV) light can worsen clinical symptoms in autoimmune diseases such as lupus.

Lupus, an autoimmune disease that can cause inflammation of the joints, skin, kidneys, blood cells, brain, heart and lungs, is caused when the immune system attacks its own tissue.

Previous research has established that in up to 80 percent of lupus patients, sunlight exposure can trigger both local skin inflammation and systemic flares, including kidney disease. But little has been understood about the underlying mechanisms that drive this process.

To define how UV light triggers kidney inflammation, the research team investigated the role of neutrophils--a type of white blood cell abundantly found in the body that acts as a first responder to any kind of inflammation and has been linked to skin and kidney tissue injury in lupus patients.

In the study, the researchers looked for markers of inflammation and injury in the skin, the blood, and the kidney at different time points following UV light exposure in mice. They were able to demonstrate that neutrophils not only infiltrated the UV light-exposed skin, but also dispersed throughout the circulatory system and migrated to the kidney.

"Interestingly, one subset of these neutrophils, the ones that we think are more damaging, first went to the skin that was exposed to the UV light and then turned around and went to the kidney," says Sladjana Skopelja-Gardner, PhD, an assistant professor of medicine at Geisel who worked with Keith Elkon, MD, at UW on the study. "That's a bit unusual--we normally think of neutrophils as short-lived cells that sort of zoom to where the inflammation is and then die off there."

The investigators found that a single exposure of skin to UV light stimulates inflammatory and injury processes in the kidney, including transient proteinuria, even in normal, healthy mice.

"To be clear, normal, healthy mice don't get the clinical type of kidney disease that you see in lupus patients," explains Skopelja-Gardner. "They get what we call subclinical injury, meaning there is an inflammatory and injury process happening in the kidney that is not visible by pathology or looking at the tissue itself. The mice recover and are fine afterwards.

"However," she adds, "this subclinical injury may lead to pathologic consequences in the vulnerable setting of pre-existing inflammation in lupus patients, and lead to kidney disease flare after exposure to sunlight."

Importantly, the inflammatory and injury markers they detected in the mouse kidneys following UV light exposure were very similar to the renal injury markers that are associated with more severe kidney damage in lupus patients. In addition, the exposure to UV light also triggered an immune response that is often expressed in most lupus patients--the type 1 interferon response--in both the skin and kidney.

"Overall, I think what our research demonstrates is that skin exposure to UV light can be the source of inflammatory pathways that are relevant to lupus, and that neutrophils play an important role as a pathogenic mediator in this process, contributing to kidney damage," says Skopelja-Gardner.

Credit: 
The Geisel School of Medicine at Dartmouth

Counting patients social determinants of health may help doctors avert fatal heart attacks

Doctors may be able to predict their patients' risks of fatal coronary heart disease more accurately by taking into account the number of adverse social factors affecting them, according to a new study led by researchers at Weill Cornell Medicine and NewYork-Presbyterian.

The researchers, whose findings appear Dec. 3 in Circulation, analyzed data from the Reasons for Geographic and Racial Differences in Stroke (REGARDS) Study that tracked cardiovascular-related health outcomes in more than 20,000 people for a decade. The new analysis showed that participants who had more adverse social determinants of health, such as low income and educational attainment, were significantly more likely to die of coronary heart disease--mostly heart attacks--during the study. For example, people with three or more social determinants of health, on a list of seven, were about 67 percent more likely to have a fatal heart attack, even when accounting for differences in age and other health factors.

The researchers suggest that doctors consider using simple counts of these factors to better estimate their patients' health risks and provide more aggressive treatment where applicable.

"Physicians tend to view social determinants of health as a peripheral part of clinical care management, but we think it should play a much more central role," said lead author Dr. Monika Safford, John J. Kuiper Professor of Medicine at Weill Cornell Medicine and chief of the Division of General Internal Medicine at Weill Cornell Medicine and NewYork-Presbyterian/Weill Cornell Medical Center.

Social determinants of health have remained on the periphery of medicine, despite their potential for improving patient risk assessment, largely because no one has demonstrated an easy way to use them in day-to-day clinical practice.

"Physicians tend to be very busy people--they're unlikely to adopt a complex tool for risk assessment," Dr. Safford said. "Our approach therefore was to keep it simple."

The analysis covered more than 22,000 people, who initially did not have diagnosed coronary heart disease, in the long-running REGARDS Study, on which Dr. Safford has been a lead investigator. The stroke-focused study has included ancillary studies of heart attacks and related health outcomes.

Dr. Safford and her colleagues identified a list of nine social determinants of health that prior research has linked individually to greater risks of heart attacks, strokes and related outcomes. They found that about half (48.8 percent) of those in the study group had two or more of these adverse social factors, and that having more of them generally predicted worse coronary heart disease outcomes during the study period. Participants with three or more social determinants were, for example, about three times more likely to suffer fatal coronary heart disease, compared to those with none of these factors.

These initial findings suggested that a count of social determinants of health could be a quick and easy source of information for doctors about their patients' coronary heart disease risks--even if it is only predictive because the factors are linked to known cardiovascular risk factors such as hypertension and obesity. However, a further analysis suggested that a high count also contains an independent signal of fatal-coronary heart disease risk.

The researchers narrowed their social determinants of health list to the seven that were most strongly linked to fatal coronary heart disease: Black race, low education, low income, living in a zip code with high poverty, residence in one of the U.S. states with the least public health infrastructure, not seeing close friends/family in the past month, and lack of health insurance. They then adjusted the outcomes data based on differences in health factors, such as a greater burden of chronic disease in the high social determinants group. They still found that people with three or more social determinants had a 67 percent greater risk of fatal coronary heart disease.

A similar analysis found that people with two or more social determinants had a 14 percent greater risk of nonfatal heart attack, although that association was not statistically significant.

Noting a patient's high number of social determinants of health could enable a cardiologist or general practitioner not only to anticipate a higher chance of bad outcomes, but also to mitigate that added risk with more intensive treatment, Dr. Safford said.

"Our group has also done studies on social determinants of health and the risks of stroke, diabetes, and heart failure, and we've had similar findings in every case, so we may be close to the point where counting social determinants of health is generally adopted into clinical practice," she said.

Credit: 
Weill Cornell Medicine

Study says friends are most valued in cultures where they may be needed most

Friends are more than just trusted confidantes, say Michigan State University researchers who have examined the cultural and health benefits of close human relationships in a new study.

"Friendships are one of the untapped resources people can draw on to pursue a happier and healthier life. They literally cost nothing and have health and well-being benefits," said William Chopik, an assistant professor of psychology at MSU and the study's senior author.

Published in Frontiers of Psychology, the study is the largest of its kind and included 323,200 participants from 99 countries. Prior studies compared only a few specific cultures to one another -- but did not take such a comprehensive view.

"We found that placing a value on friendship was good for people's health and well-being regardless of where they lived. However, looking at friendships as an important part of life is more important in some cultures than it is in others."

Using the World Values Survey, the researchers pulled data from multiple sources including datasets on friendship, health, happiness findings; economic variables; and cultural variables.

Researchers found that around the world those who invest in friendships enjoy better physical and psychological health, particularly older adults or those with less education. The benefits are especially evident in cultures that are more individualistic, unequal or constraining.

"People who come from more privileged settings have a lot of resources that contribute to their health and happiness, but it looks like -- for those who don't have those resources -- friendships might serve as a particularly important factor in their lives," Chopik said.

One of the goals of MSU's Close Relationships Lab -- founded and run by Chopik -- is to examine friendships and study them in ways that people can improve their lives for the better.

"In today's world there's a general feeling that we're in a 'friendship crisis' in which people are lonely and want friends but struggle to make them," Chopik said. "We show here that they're beneficial for nearly everyone, everywhere. But why are they so hard to form and keep? That's what we're working on next."

Credit: 
Michigan State University

Sloan Kettering Institute scientists solve a 100-year-old mystery about cancer

The year 2021 marks the 100th anniversary of a fundamental discovery that's taught in every biochemistry textbook. In 1921, German physician Otto Warburg observed that cancer cells harvest energy from glucose sugar in a strangely inefficient manner: rather than "burn" it using oxygen, cancer cells do what yeast do -- they ferment it. This oxygen-independent process occurs quickly, but leaves much of the energy in glucose untapped.

Various hypotheses to explain the Warburg effect have been proposed over the years, including the idea that cancer cells have defective mitochondria -- their "energy factories" -- and therefore cannot perform the controlled burning of glucose. But none of these explanations has withstood the test of time. (Cancer cells' mitochondria work just fine, for example.)

Now a research team at the Sloan Kettering Institute led by immunologist Ming Li offers a new answer, based on a hefty set of genetic and biochemical experiments and published January 21 in the journal Science.

It comes down to a previously unappreciated link between Warburg metabolism and the activity of a powerhouse enzyme in the cell called PI3 kinase.

"PI3 kinase is a key signaling molecule that functions almost like a commander-in-chief of cell metabolism," Dr. Li says. "Most of the energy-costly cellular events in cells, including cell division, occur only when PI3 kinase gives the cue."

As cells shift to Warburg metabolism, the activity of PI3 kinase is increased, and in turn, the cells' commitment to divide is strengthened. It's a bit like giving the commander-in-chief a megaphone.

The findings revise the commonly accepted view among biochemists that sees metabolism as secondary to cell signaling. They also suggest that targeting metabolism could be an effective way to thwart cancer growth.

Challenging the Textbook View

Dr. Li and his team, including graduate student Ke Xu, studied Warburg metabolism in immune cells, which also rely on this seemingly inefficient form of metabolism. When immune cells are alerted to the presence of an infection, a certain type called T cells shift from the typical oxygen-burning form of metabolism to Warburg metabolism as they grow in number and ramp up infection-fighting machinery.

The key switch that controls this shift is an enzyme called lactate dehydrogenase A (LDHA), which is made in response to PI3 kinase signaling. As a result of this switch, glucose remains only partially broken down and the cell's energy currency, called ATP, is quickly generated in the cell's cytosol. (In contrast, when cells use oxygen to burn glucose, the partially broken down molecules travel to the mitochondria and are further broken down there to make ATP on a delay.)

Dr. Li and his team found that in mice, T cells lacking LDHA could not sustain their PI3 kinase activity, and as a result could not effectively fight infections. To Dr. Li and his team, this implied that this metabolic enzyme was controlling a cell's signaling activity.

"The field has worked under the assumption that metabolism is secondary to growth factor signaling," Dr. Li says. "In other words, growth factor signaling drives metabolism, and metabolism supports cell growth and proliferation. So the observation that a metabolic enzyme like LDHA could impact growth factor signaling through PI3 kinase really caught our attention."

Like other kinases, PI3 kinase relies on ATP to do its work. Since ATP is the net product of Warburg metabolism, a positive feedback loop is set up between Warburg metabolism and PI3 kinase activity, securing PI3 kinase's continued activity -- and therefore cell division.

As for why activated immune cells would preferentially resort to this form of metabolism, Dr. Li suspects it has to do with the cells' need to produce ATP quickly to ramp up their cell division and infection-fighting machinery. The positive feedback loop ensures that once this program is engaged, it will be sustained until the infection is eradicated.

The Cancer Connection

Though the team made their discoveries in immune cells, there are clear parallels to cancer.

"PI3 kinase is a very, very critical kinase in the context of cancer," Dr. Li says. "It's what sends the growth signal for cancer cells to divide, and is one of the most overly active signaling pathways in cancer."

As with immune cells, cancer cells may employ Warburg metabolism as a way to sustain the activity of this signaling pathway and therefore ensure their continued growth and division. The results raise the intriguing possibility that doctors could curb cancer growth by blocking the activity of LDHA -- the Warburg "switch."

Credit: 
Memorial Sloan Kettering Cancer Center

Study suggests coffee temporarily counteracts effect of sleep loss on cognitive function

A new study exploring the impact of repeated sleep loss during a simulated working week has found that consuming caffeinated coffee during the day helps to minimize reductions in attention and cognitive function, compared to decaffeinated coffee1.

While this effect occurred in the first three-to-four days of restricted sleep, by the fifth and final day, no difference was seen between caffeinated and decaffeinated coffee drinkers. This therefore suggests that the beneficial effects of coffee for people with restricted sleep are temporary1.

It is estimated that over 30% of adult Western populations sleep less than the recommended seven to eight hours on weekday nights and 15% regularly sleep less than six hours2,3. This can have a considerable impact on people's health and wellbeing, including causing sleepiness and impairing vigilance and attention4.

Denise Lange, study co-author, commented: "Previous research suggests that acute consumption of caffeinated coffee can reduce the impact of sleep deprivation on deficits of attention and cognitive function in a short-term setting. This study is among the first to examine whether this effect can be translated into a real-world situation, where caffeinated drinks are commonly consumed every day by people who experience chronic sleep restriction. Our study indicates that moderate coffee intake can mitigate some repercussions of reduced sleep over a few days, however, this is not a substitute for a good night's sleep in the long term."

The study was conducted at the state-of-the-art Institute of Aerospace Medicine, in Cologne Germany. 26 participants carrying a distinct genotype of the gene encoding the adenosine A2A receptor were randomly assigned to groups either drinking caffeinated coffee (containing 300 mg caffeine) or decaffeinated coffee under double-blind conditions. During five days, the sleep of all participants was restricted to five hours per night and each day they rated their subjective sleepiness and were tested on levels of vigilance, alertness, reaction-time, accuracy and memory1.

Credit: 
Kaizo

Study pins down number of Americans with most common form of lupus

Just over 200,000 Americans suffer from systemic lupus erythematosus, or SLE, a condition in which the body's immune system mistakenly attacks its own healthy tissues, especially joints and skin, a new study shows.

Led by a researcher at NYU Grossman School of the Medicine, the study provides the first national estimate of how widespread the autoimmune disease is since the U.S. Centers for Disease Control and Prevention (CDC) set up a half dozen state registries to track the illness more than a decade ago. SLE affects mostly women, can be fatal, and often involves debilitating flare-ups of fatigue and pain that keep nearly half of adult patients from working.

Importantly, the researcher says the report, publishing in the journal Arthritis and Rheumatology online Jan. 21, comes statistically close to officially reclassifying the illness as a rare disease, which disproportionately affects mostly American Indian/Alaskan Native, Black, and Hispanic females. The U.S. Rare Diseases Act of 2002 classifies such conditions as those affecting 200,000 or fewer Americans.

Until now, researchers had relied on disease estimates that were larger but unverified.

"Our study potentially redefines systemic lupus erythematosus as a rare disease in the United States and lays the groundwork for where we need to focus our efforts to reduce the burden of this disease on Americans," says study lead investigator and rheumatologist Peter Izmirly, MD. Izmirly is an associate professor in the Department of Medicine at NYU Langone Health.

Rare-disease classification could, the investigator says, significantly change efforts to study and treat SLE by decreasing the number of study participants needed for testing new treatments and shaping the design of clinical trials needed before seeking regulatory approval. He also says the team's findings could help plan which neighborhoods or population groups need extra medical resources, including specialty rheumatology clinics, to combat SLE.

Current treatments for lupus, he notes, include steroids or other anti-inflammatory and immunosuppressing medications, especially newer biologic drugs, made from living cells, to prevent patients' immune system's attack on their tissues.

For the study, researchers at NYU Langone and elsewhere analyzed records for 5,417 adults and children diagnosed with SLE since 2002 at all of the state registries for the disease, as well as the Indian Native Health Service. They then calculated the number of people with SLE for every gender and ethnic group and applied those demographic numbers to national population statistics from the 2018 U.S. Census. They concluded that among every 100,000 people nationwide, 72.8 had SLE, for a total of 204,295 out of a population of 330 million.

Their calculations also found that nine times more women than men have SLE, the dominant form of lupus. SLE rates were highest among Native American/Alaskan Native females, at 270.6 per 100,000. Black females ranked next, at 230.9 per 100,000, followed by Hispanic females, at 120.7 per 100,000. Similar disparities were seen among males with SLE, with American Indians/Alaskan Natives having the highest number, at 53.8 per 100,000, and Black males next, at 26.7 per 100,000.

Credit: 
NYU Langone Health / NYU Grossman School of Medicine

Research finds people more likely to follow Covid rules when friends and family do

New research has shown that people are more likely to follow Covid-19 restrictions based on what their friends do, rather than their own principles.

Research led by the University of Nottingham carried out in partnership with experts in collective behaviour from British, French, German and American universities shows how social influence affects people's adherance to government restrictions. The researchers found that the best predictor of people's compliance to the rules was how much their close circle complied with the rules, which had an even stronger effect than people's own approval of the rules.

The research published in British Journal of Psychology highlights a blindspot in policy responses to the pandemic. It also suggests that including experts in human and social behaviour is crucial when planning the next stages of the pandemic response, such as how to ensure that people comply with extended lockdowns or vaccination recommendations.

The lead researcher, Dr Bahar Tunçgenç from the University of Nottingham's School of Psychology and a research affiliate at the University of Oxford said: "When coronavirus first hit the UK in March, I was struck by how differently the leaders in Europe and Asia were responding to the pandemic. While the West emphasised 'each person doing the right thing', pandemic strategies in countries like Singapore, China and South Korea focussed on moving the collective together as a single unit. To understand what would work most effectively for bringing people on board in this moment of crisis, we set out to conduct a global study."

To investigate the role that social networks might play in preventing the spread of Covid-19, the researchers asked people from over 100 countries how much they, and their close social circle, approved of and followed the Covid-19 rules currently in place in their area.

The researchers found that people didn't simply follow the rules if they felt vulnerable or were personally convinced. Most diligent followers of the guidelines were those whose friends and family also followed the rules. Close circle's compliance had an even stronger effect than people's own approval of the rules. This discovery applied to all age groups, genders, countries, and was independent of the severity of the pandemic and strength of restrictions.The study also revealed that people who were particularly bonded to their country were more likely to stick to lockdown rules - the country was like family in this way, someone for whom one is willing to stick their neck out.

"Public policies are on the wrong track: We see scientists and politicians trying to boost the public's approval of the measures, so that vaccination campaigns and lockdowns get the support of the citizens, but approval does not mean compliance! You may make up your own mind about the measures, or listen to experts, but eventually, what you do depends on what your close friends do" says Ophelia Deroy, who is a professor of philosophy of mind and neuroscience at Ludwig Maximilian University of Munich.

Dr Tuncgenc concludes: "There is much that human behaviour research can offer to implement effective policies for the Covid-19 challenges we will continue to face in the future. Practical steps could include social apps, similar to social-based excercise apps, which tell people whether their close friends are enrolled for the vaccine. Using social media to demonstrate to your friends that you are following the rules, rather than expressing outrage at people who aren't following them could also be a more impactful approach. At national and local levels, public messages by trusted figures can emphasise collective values, such as working for the benefit of our loved ones and the community. Our message to policymakers is that even when the challenge is to practise social distancing, social closeness is the solution!"

Credit: 
University of Nottingham

The important role of pharmacists for older adults' health

Pharmacists play an important role in managing medication-based therapies for older community-dwelling patients, according to a study published in the British Journal of Clinical Pharmacology.

In the study of patients aged 65 years and older who came to a pharmacist-led outpatient clinic at a general hospital in Beijing, China between 2016 and 2018, pharmacists were helpful not only for identifying and solving drug-related problems, but also for improving measures such as blood pressure and cholesterol, and for reducing the cost of medications for patients.

"To the best of our knowledge, this study was the first to evaluate the outcomes of pharmacist-led medication therapy management services in ambulatory elderly patients in mainland China," the authors wrote.

Credit: 
Wiley